TrialNCT01233960Phase 3Completed
Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease
Study sponsor: Mesoblast, Inc.
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2014-09-15Actual
Enrollment · participants73Actual
Source updated2026-03-11Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.